SCHEMBL14970313

SCHEMBL14970313

COC(=O)/C(=C\c1ccc(N(C)C)cc1)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.57
ALDH1A1 P00352 6/20 0.57
KMT2A Q03164 6/20 0.57
LMNA P02545 3/20 0.57
GAA P10253 2/20 0.57
MEN1 O00255 3/20 0.55
RAB9A P51151 7/20 0.52
MAPK1 P28482 3/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
NPC1 O15118 5/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
PKM P14618 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
HPGD P15428 1/20 0.51
CHIA Q9BZP6 1/20 0.49
APP P05067 1/20 0.49
AKR1C1 Q04828 1/20 0.49
KDM4E B2RXH2 2/20 0.48
SNCA P37840 1/20 0.48
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11743667 0.87 AKR1C1 (0.63) MAPTALDH1A1KMT2ALMNAMEN1
SCHEMBL4007167 0.87 AKR1C1 (0.63) MAPTALDH1A1KMT2ALMNAMEN1
SCHEMBL4007174 0.87 AKR1C1 (0.63) MAPTALDH1A1KMT2ALMNAMEN1
SCHEMBL14964849 0.86 AKR1C1 (0.68) MAPTALDH1A1KMT2ALMNAGAA
SCHEMBL14964850 0.86 AKR1C1 (0.68) MAPTALDH1A1KMT2ALMNAGAA
SCHEMBL391072 0.86 MAPT (0.61) MAPTALDH1A1KMT2ALMNAGAA
SCHEMBL4008619 0.84 MEN1 (0.55) MAPTALDH1A1KMT2ALMNAMEN1
SCHEMBL4008615 0.84 MEN1 (0.55) MAPTALDH1A1KMT2ALMNAMEN1
SCHEMBL6383804 0.84 MAPT (0.58) MAPTALDH1A1KMT2ALMNAMEN1
SCHEMBL6383807 0.84 MAPT (0.58) MAPTALDH1A1KMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072390-A2 STILBENE COMPOUNDS AS PPAR BETA/DELTA INHIBITORS FOR TREATING PPAR BETA/DELTA TRANSMITTED ILLNESSES PHILIPPS-UNIVERSITÄT MARBURG (DE) 2013-05-23 WO disclosed